Current role
Biotechnology · Healthcare
Board Member
2022-10-27–present
Thomas J. Lynch Jr., MD
Board Member
Foghorn Therapeutics Inc. (FHTX)Equibles does not estimate personal net worth.
About Thomas J. Lynch Jr., MD
Thomas J. Lynch Jr., MD is recorded as Board Member at Foghorn Therapeutics Inc. (FHTX) since October 27, 2022. Foghorn Therapeutics Inc. reported in an 8-K filed October 27, 2022 that Thomas J. Lynch Jr., MD was appointed Class I Director, effective October 27, 2022. Foghorn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Foghorn Therapeutics Inc. includes Adrian Gottschalk (CEO and Board Member), Jeff Sacher (CFO), Kristian F. Humer (CFO and Chief Accounting Officer) and 7 others.
“On October 27, 2022, the Board of Directors (the "Board") of Foghorn Therapeutics Inc. (the "Company"), upon the recommendation of the Board's Nominating and Corporate Governance Committee, elected Thomas J. Lynch Jr., MD to the Board as a Class I Director with a term to expire at the 2024 annual meeting of stockholders.”
Affiliation history
-
Current
2022-10-27–present
Company network
Leadership on record at Foghorn Therapeutics Inc.
- Adrian Gottschalk CEO, Board Member
- Jeff Sacher CFO
- Kristian F. Humer CFO, Chief Accounting Officer
- Ryan D. Maynard CFO
- Ryan Maynard CFO
- Stephen J. DiPalma CFO
- Steven Bellon CTO
- B. Lynne Parshall Board Member
- Ian F. Smith Board Member
- Neil J. Gallagher, M.D., Ph.D. Board Member